Sarmen Sarkissian, MD of UC Irvine Health discusses the highlights in prostate cancer research, specifically a phase III clinical trial on the use of Abiraterone in the treatment of prostate cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Impact of Abiraterone on Overall Survival for Patients with Advanced Prostate Cancer
